Both in Pharmaceuticals
Insmed vs Roivant Sciences
Over the past year INSM returned −39.8% and ROIV returned +92.4%; their daily moves had a correlation of 0.24.
INSM −39.8% ROIV +92.4%Growth of $1, one year, split-adjusted
| Metric | INSM | ROIV |
|---|---|---|
| Price | $110.00 | $38.23 |
| Market cap | $24.13B | $27.61B |
| Today | +5.32% | +6.08% |
| 1 month | +4.5% | +7.6% |
| 6 months | −19.8% | +32.7% |
| Year to date | −36.8% | +76.2% |
| 1 year | −40.9% | +95.1% |
| Revenue growth (YoY) | +268.4% | −33.5% |
| Gross margin | 85.1% | 100.0% |
| Net margin | −19.1% | −13164.8% |
| P/E (TTM) | — | — |
| Price / sales | 15.9× | 3,666.3× |
| Net cash | $569.9M | $3.84B |
| Dividend yield | — | — |
| Volatility (60d) | 48.6% | 50.3% |
| Short % of float | 6.3% | 8.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).